Bio-Rad Laboratories Inc

BUW

Company Profile

  • Business description

    Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

  • Contact

    1000 Alfred Nobel Drive
    HerculesCA94547
    USA

    T: +1 510 724-7000

    E: [email protected]

    https://www.bio-rad.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    7,450

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,782.5016.90-0.19%
CAC 407,981.765.73-0.07%
DAX 4024,400.6592.730.38%
Dow JONES (US)49,363.88322.24-0.65%
FTSE 10010,330.556.800.07%
HKSE25,797.85122.670.48%
NASDAQ25,870.71220.02-0.84%
Nikkei 22559,903.92646.67-1.07%
NZX 50 Index12,837.56136.76-1.05%
S&P 5007,353.6149.44-0.67%
S&P/ASX 2008,558.1015.00-0.17%
SSE Composite Index4,169.320.21-0.01%

Market Movers